These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2223632)

  • 21. Stimulation of erythroid engraftment by recombinant human erythropoietin in ABO-compatible, HLA-identical, allogeneic bone marrow transplant patients.
    Vannucchi AM; Bosi A; Grossi A; Guidi S; Saccardi R; Lombardini L; Rossi-Ferrini P
    Leukemia; 1992 Mar; 6(3):215-9. PubMed ID: 1564959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant human erythropoietin is effective in correcting erythropoietin-deficient anaemia after allogeneic bone marrow transplantation.
    Locatelli F; Pedrazzoli P; Barosi G; Zecca M; Porta F; Liberato L; Gambarana D; Nespoli L; Cazzola M
    Br J Haematol; 1992 Apr; 80(4):545-9. PubMed ID: 1581240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Red blood cell precursor mass as an independent determinant of serum erythropoietin level.
    Cazzola M; Guarnone R; Cerani P; Centenara E; Rovati A; Beguin Y
    Blood; 1998 Mar; 91(6):2139-45. PubMed ID: 9490701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of recombinant human erythropoietin in allogeneic bone marrow transplant donor/recipient pairs.
    Mitus AJ; Antin JH; Rutherford CJ; McGarigle CJ; Goldberg MA
    Blood; 1994 Apr; 83(7):1952-7. PubMed ID: 8142661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impaired erythropoietin response to anemia after bone marrow transplantation.
    Miller CB; Jones RJ; Zahurak ML; Piantadosi S; Burns WH; Santos GW; Spivak JL
    Blood; 1992 Nov; 80(10):2677-82. PubMed ID: 1421381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prolactin: a possible mediator of graft-versus-host disease following allogeneic bone marrow transplantation in humans.
    Hinterberger-Fischer M; Kier P; Spona J; Sebesta C; Tiefengraber E; Habertheuer KH; Ruckser R; Schmid A; Kalhs P; Lechner K
    Bone Marrow Transplant; 1994 Sep; 14(3):403-6. PubMed ID: 7994262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurologic complications of autologous and allogeneic bone marrow transplantation in patients with leukemia: a comparative study.
    Graus F; Saiz A; Sierra J; Arbaiza D; Rovira M; Carreras E; Tolosa E; Rozman C
    Neurology; 1996 Apr; 46(4):1004-9. PubMed ID: 8780080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of CBFbeta/MYH11 fusion transcripts in patients with inv(16) acute myeloid leukemia after allogeneic bone marrow or peripheral blood progenitor cell transplantation.
    Elmaagacli AH; Beelen DW; Kroll M; Trzensky S; Stein C; Schaefer UW
    Bone Marrow Transplant; 1998 Jan; 21(2):159-66. PubMed ID: 9489633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination therapy with G-CSF and erythropoietin after autologous bone marrow transplantation for lymphoid malignancies: a randomized trial.
    Vannucchi AM; Bosi A; Ieri A; Guidi S; Saccardi R; Lombardini L; Linari S; Laszlo D; Longo G; Rossi-Ferrini P
    Bone Marrow Transplant; 1996 Apr; 17(4):527-31. PubMed ID: 8722349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant human erythropoietin therapy is very effective after an autologous peripheral blood stem cell transplant when started soon after engraftment.
    Baron F; Frère P; Fillet G; Beguin Y
    Clin Cancer Res; 2003 Nov; 9(15):5566-72. PubMed ID: 14654537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of erythropoietin in the treatment of post-bone marrow transplantation anemia.
    Vannucchi AM; Bosi A; Grossi A; Guidi S; Saccardi R; Bacci P; Lombardini L; Rossi-Ferrini P
    Int J Artif Organs; 1993 Dec; 16 Suppl 5():8-12. PubMed ID: 8014003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intensively timed induction therapy followed by autologous or allogeneic bone marrow transplantation for children with acute myeloid leukemia or myelodysplastic syndrome: a Childrens Cancer Group pilot study.
    Woods WG; Kobrinsky N; Buckley J; Neudorf S; Sanders J; Miller L; Barnard D; Benjamin D; DeSwarte J; Kalousek D
    J Clin Oncol; 1993 Aug; 11(8):1448-57. PubMed ID: 8336184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Second allogeneic bone marrow transplantation after myeloablative conditioning analysis of 43 cases from single institution.
    Al-Qurashi F; Ayas M; Al Sharif F; Ibrahim E; Sahovic E; Al Mahr M; Chaudhri N; Al Mohareb F; Al Zahrani H; Al Jefri A; Al Omar H; Al Shanqeeti A; Seth P; Aslam M; El Solh H; Aljurf M
    Hematology; 2004 Apr; 9(2):123-9. PubMed ID: 15203867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum interleukin-12 levels in patients undergoing allogeneic or autologous bone marrow transplantation.
    Bonnotte B; Burdiles AM; Chehimi J; Carayol G; Pardoux C; Dietrich PY; Kubin M; Blay JY; Caignard A; Ibrahim A; Robinet E; Hayat M; Pico JL; Bourhis JH; Chouaib S
    Eur Cytokine Netw; 1996 Sep; 7(3):389-94. PubMed ID: 8954182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accelerated erythroid repopulation with no stem-cell competition effect in children treated with recombinant human erythropoietin after allogeneic bone marrow transplantation.
    Locatelli F; Zecca M; Beguin Y; Giorgiani G; Ponchio L; De Stefano P; Cazzola M
    Br J Haematol; 1993 Aug; 84(4):752-4. PubMed ID: 8217839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Level of renal function and serum erythropoietin levels independently predict anaemia post-renal transplantation.
    Sinnamon KT; Courtney AE; Maxwell AP; McNamee PT; Savage G; Fogarty DG
    Nephrol Dial Transplant; 2007 Jul; 22(7):1969-73. PubMed ID: 17353209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Re-establishment of erythropoietin responsiveness in end-stage renal failure following renal transplantation.
    Jeffrey RF; Kendall RG; Prabhu P; Norfolk DR; Will EJ; Davison AM
    Clin Nephrol; 1995 Oct; 44(4):241-7. PubMed ID: 8575124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant human erythropoietin therapy after allogeneic hematopoietic cell transplantation with a nonmyeloablative conditioning regimen: low donor chimerism predicts for poor response.
    Vanstraelen G; Baron F; Willems E; Bonnet C; Hafraoui K; Frère P; Fillet G; Beguin Y
    Exp Hematol; 2006 Jul; 34(7):841-50. PubMed ID: 16797411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Reconstitution of peripheral blood lymphocytes in patients treated with bone marrow transplantation: comparison between allogeneic and autologous transplantation].
    Parra C; Roldán E; Rodríguez C; Pérez de Oteyza J; Oteho E; López J; Maldonado MS; García Laraña J; Muñoz A; Odriozola J; Brieva JA
    Med Clin (Barc); 1999 Jun; 113(1):1-5. PubMed ID: 10422068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcome of autologous rescue after failed engraftment of allogeneic marrow.
    Mehta J; Powles R; Singhal S; Horton C; Treleaven J
    Bone Marrow Transplant; 1996 Feb; 17(2):213-7. PubMed ID: 8640169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.